Pharmaceutical compositions comprising inhibitory substances of the reuptake of noradrenaline, dopamine and serotonin, combined with Aminoacid in the treatment of Obesity and overweight

摘要

The present invention relates to the general pharmaceutical industry and the pharmaceutical industry for the production of drugs for the control of obesity and overweight. More specifically, it consists of a substance that inhibits the reabsorption of adrenaline, dopamine and serotonin, as well as an amino acid. The compound is characterized by a mixture or association of specific inhibitors of adrenaline, dopamine, and serotonin reabsorbed by an amino acid called sibutramina and an amino acid called l-cardine.They produce a synergistic product to treat obesity and overweight, with fewer side effects.